# Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

> **NCT02830165** · NA · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 11 (actual)

## Conditions studied

- Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7
- Stage II Prostate Adenocarcinoma AJCC v7
- Stage III Prostate Adenocarcinoma AJCC v7

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Quality-of-Life Assessment
- **RADIATION:** Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT02830165
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-15
- **Primary completion:** 2020-05-09
- **Final completion:** 2022-05-27
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2024-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02830165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02830165, "Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02830165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*